Moreover, MK-2206 blocking AKT activity greatly attenuated the cancer-promoting effect of SCARNA12 in CRC cells, supporting the theory that SCARNA12 promotes the proliferation of CRC cells by activating the PI3K/AKT signaling pathway. This evidence concerns the gene AKT1 and colorectal carcinoma.